0OCD.LSE Medistim ASA

Healthcare Commercial Services & Supplies London Exchange
246.84 NOK
Close of Nov 3, 2026
178.94 309.00
Market cap
NOK 4.49B
P/E
60.4x
P/B
-
ROE
41.1%
Dividend yield
2.57%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0OCD.LSE undervalued?

Graham number

The Graham number of Medistim ASA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medistim ASA fundamental analysis

No fundamental analysis for Medistim ASA yet.

Medistim ASA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ult…

Full company profile